Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Sunrun CEO Mary Powell Named to the 2024 TIME100 Climate List of Most Influential Leaders In Climate
-
ZAGG Unveils Pro Keys 2: New Wireless Keyboard Designed to Maximize iPad Productivity
-
Kailera Therapeutics Appoints Scott M. Akamine as Chief Legal Officer
-
PEAK:AIO Achieves 400% U.S. Growth Through Innovative, Energy-Efficient AI Data Solutions
-
Opus Genetics Announces Financial Results for Third Quarter 2024 and Provides Corporate Update
-
Rectify Pharma to Host Virtual R&D Event on RTY-694 for Primary Sclerosing Cholangitis and Other Hepatobiliary Diseases on November 21, 2024
-
Snyk Acquires Developer-First DAST Provider Probely
-
Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights
-
Duos Technologies Group Sets Third Quarter 2024 Earnings Call for Wednesday, November 20, 2024 at 4:00 PM ET
-
Corbus Pharmaceuticals to Present at the Jefferies London Healthcare Conference
-
Dave’s Hot Chicken Partners with Qu to Drive Innovation and Enhance Guest Experiences
-
InterDigital To Present At 2024 RBC Capital Markets Technology, Internet, Media & Telecommunications Conference
-
CTERA Delivers Next-Generation Data Observability with CTERA Insight Service
-
NV5 Awarded $46 Million in Contracts by Western Utilities to Support Fire Mitigation and Grid Hardening Efforts
-
Majority of Canada’s drivers believe unpredictable weather driven by climate change makes winter tires more important than ever: Survey
-
Replimune Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate Update
-
Pan American Energy Announces Proposed Share Consolidation
-
Sysco to Webcast Presentation at the 2024 Morgan Stanley Global Consumer & Retail Conference
-
Actuate Announces FDA Rare Pediatric Disease Designation Granted to Elraglusib for Treatment of Ewing Sarcoma
-
Intercept Receives Complete Response Letter from FDA Addressing OCALIVA supplemental New Drug Application (sNDA)
-
Lifeward Ltd. Reports Third Quarter 2024 Financial Results
-
Protara Therapeutics Announces Third Quarter 2024 Financial Results and Provides a Business Update
-
Golden Matrix Group Inc. Reports Strong Q3 2024 Earnings and Continued Operational Growth
-
Enlivex Announces the Enrollment and Dosing of the First 10 Patient in the Randomized Phase II Stage of its Allocetra Trial in Patients with Moderate to Severe Knee Osteoarthritis
-
Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences
-
Magnite Empowers TCL’s Ad-Supported Business with Streaming Technology Suite Integration
-
Introducing a Wide Portfolio of IGBT 7 Power Devices Optimized for Applications Across Sustainability, E-Mobility and Data Centers
-
Theriva™ Biologics Reports Third Quarter 2024 Operational Highlights and Financial Results
-
OnTerra Systems Announces New 2.0 Version of RouteSavvy Route Planning Software
-
Mission Produce to Participate in the Stephens Annual Investment Conference
-
Vor Bio to Participate in the Stifel 2024 Healthcare Conference
-
Ekso Bionics to Participate at the 15th Annual Craig-Hallum Alpha Select Conference
-
Northern Technologies International Corporation to Announce Fiscal 2024 Fourth-Quarter Financial Results and Host Conference Call
-
RTI to Exhibit and Present at I/ITSEC 2024
-
Quest Resource Holding Corporation to Present and Host 1x1 Investor Meetings at the 16th Annual Southwest IDEAS Investor Conference on November 20th and 21st in Dallas, TX
-
Helio Genomics’ Chief Medical Advisor to Present Superior Performance of the Company’s Multi-Analyte Blood Test, HelioLiver, for Early Cancer Detection at the 2024 American Association for the Stu
-
Taco John’s Serves Up Festive Flavors with the Ultimate Queso Takeover and the Return of Seasonal Favorites
-
Alexandra Gucci’s AGCF Announces Inaugural Art Auction at LA Fashion Week
-
Reviva Announces Enrollment Update for Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia
-
MAX Power Advances Natural Hydrogen Initiatives
-
AltruBio to Participate in the Upcoming Jefferies London Healthcare Conference and the Piper Sandler 36th Annual Healthcare Conference
-
Tempest Receives FDA Study May Proceed for Pivotal Phase 3 Trial of Amezalpat Combination Therapy for the Treatment of First-Line Hepatocellular Carcinoma
-
Artelo Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update
-
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2024 Financial Results
-
FDH Electronics Signs Value-Added Distribution Agreement with Amphenol Military High Speed
-
GBI Releases Updated Green Globes for Core & Shell (CS) and Green Globes for Sustainable Interiors (SI) Certification Programs
-
Provident Bank Expands Mortgage Warehouse Lending Team Adding Vice President to Support Growth Strategy
-
Transpire Bio Announces Corporate Office Expansion
-
Tria Federal Announces Acquisition of Softrams, Creating a New Federal Health Powerhouse
-
iCAD's ProFound Detection Version 4.0 Gains FDA Clearance

